Cargando…

Androgens Profile in Blood Serum and Follicular Fluid of Women With Poor Ovarian Response During Controlled Ovarian Stimulation Reveals Differences Amongst POSEIDON Stratification Groups: A Pilot Study

Patients with poor ovarian response (POR) to exogenous gonadotropins stimulation for assisted reproductive technology (ART) have decreased circulating androgens during spontaneous cycles. The Patient-Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) is a 4-tier stratification...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuentes, Ariel, Sequeira, Karina, Tapia-Pizarro, Alejandro, Muñoz, Alex, Salinas, Abril, Céspedes, Pablo, Escalona, Javier, Godoy, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646462/ https://www.ncbi.nlm.nih.gov/pubmed/31379738 http://dx.doi.org/10.3389/fendo.2019.00458

Ejemplares similares

The POSEIDON stratification - moving from poor ovarian response to low prognosis
por: Roque, Matheus, et al.
Publicado: (2021)

Efficacies of different ovarian hyperstimulation protocols in poor ovarian responders classified by the POSEIDON criteria
por: Li, Fei, et al.
Publicado: (2020)

Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification
por: Grisendi, Valentina, et al.
Publicado: (2019)

Comparison of ART outcome in patients with poor ovarian response according to POSEIDON criteria
por: Lee, Hyun Joo, et al.
Publicado: (2022)

Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept
por: Drakopoulos, Panagiotis, et al.
Publicado: (2020)

Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
por: Humaidan, Peter, et al.
Publicado: (2019)

Comparative Effectiveness of Mild or Conventional GnRH-Antagonist Protocols for Ovarian Stimulation in Poor Responders (Poseidon Group 4)
por: Le, Hoang, et al.
Publicado: (2020)

Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria
por: Farimani, Marzieh, et al.
Publicado: (2021)

Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria
por: Grynberg, Michael, et al.
Publicado: (2019)

Correction to: Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: a retrospective study according to the POSEIDON criteria
por: Farimani, Marzieh, et al.
Publicado: (2021)

Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW
por: Esteves, Sandro C., et al.
Publicado: (2021)

Luteal Phase Stimulation in the Same Cycle Is an Effective Strategy to Rescue POSEIDON Poor Responders with No Embryos after the First Follicular Stimulation
por: Majumdar, Abha, et al.
Publicado: (2023)

Comparison of Cumulative Live Birth Rates between Flexible and Conventional Progestin-Primed Ovarian Stimulation Protocol in Poor Ovarian Response Patients According to POSEIDON Criteria: A Cohort Study
por: Chen, Ying, et al.
Publicado: (2023)

Predictive Factors for Live Birth in Fresh In Vitro Fertilization/Intracytoplasmic Sperm Injection Treatment in Poor Ovarian Reserve Patients Classified by the POSEIDON Criteria
por: Li, Fei, et al.
Publicado: (2021)

Co-Administration of Clomiphene Citrate and Letrozole in Mild Ovarian Stimulation Versus Conventional Controlled Ovarian Stimulation Among POSEIDON Group 4 Patients
por: Lin, Hsin-Ta, et al.
Publicado: (2022)

Reply: The low responder according to the POSEIDON criteria: is the prognosis really poor?
por: Leijdekkers, Jori A, et al.
Publicado: (2019)

Toll-Like Receptors Expression in Follicular Cells of Patients with Poor Ovarian Response
por: Taghavi, Seyed Abdolvahab, et al.
Publicado: (2014)

Regulation of the ovarian follicular vasculature
por: Fraser, Hamish M
Publicado: (2006)

The Effect of Growth Hormone on the Clinical Outcomes of Poor Ovarian Reserve Patients Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection Treatment: A Retrospective Study Based on POSEIDON Criteria
por: Cai, Mei-hong, et al.
Publicado: (2019)

The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
por: Humaidan, Peter, et al.
Publicado: (2016)

Management Strategies for POSEIDON's Group 1
por: Polyzos, Nikolaos P., et al.
Publicado: (2019)

Management Strategies for POSEIDON Group 2
por: Sunkara, Sesh Kamal, et al.
Publicado: (2020)

Effectiveness of oestrogen pretreatment in patients with expected poor ovarian response (POSEIDON groups 3 and 4) undergoing GnRH antagonist protocol: study protocol for a randomised controlled trial
por: Han, Qiao-Song, et al.
Publicado: (2023)

Dehydroepiandrosterone supplementation and the impact of follicular fluid metabolome and cytokinome profiles in poor ovarian responders
por: Viardot-Foucault, Veronique, et al.
Publicado: (2023)

Comparative analyses in transcriptome of human granulosa cells and follicular fluid micro-environment between poor ovarian responders with conventional controlled ovarian or mild ovarian stimulations
por: Liu, Xiaoping, et al.
Publicado: (2022)

Autophagy in Ovarian Follicular Development and Atresia
por: Zhou, Jiawei, et al.
Publicado: (2019)

LH supplementation of ovarian stimulation protocols influences follicular fluid steroid composition contributing to the improvement of ovarian response in poor responder women
por: Marchiani, S., et al.
Publicado: (2020)

POSEIDON: The secrets of the Trident Node monitoring tool
por: Kuffo Rivero, Leonardo Xavier
Publicado: (2018)

Management Strategies for POSEIDON Groups 3 and 4
por: Haahr, Thor, et al.
Publicado: (2019)

The best execution of the DuoStim strategy (double stimulation in the follicular and luteal phase of the same ovarian cycle) in patients who are poor ovarian responders
por: Luo, Yanqun, et al.
Publicado: (2020)

Transcriptomes of bovine ovarian follicular and luteal cells
por: Romereim, Sarah M., et al.
Publicado: (2016)

Ovarian Follicular Lymphoma Diagnosed Due to Hydronephrosis
por: Noguchi, Shinsuke, et al.
Publicado: (2022)

Commentary: Management Strategies for POSEIDON Groups 3 and 4
por: Bühler, Klaus F.
Publicado: (2020)

Commentary: Management Strategies for POSEIDON Groups 3 and 4
por: Fischer, Robert, et al.
Publicado: (2020)

Poor ovarian reserve
por: Jirge, Padma Rekha
Publicado: (2016)

The Role of Androgen Receptor Signaling in Ovarian Cancer
por: Mizushima, Taichi, et al.
Publicado: (2019)

Luteal phase ovarian stimulation for poor ovarian responders
por: Zhang, Wei, et al.
Publicado: (2018)

Factors Influencing Follicular Output Rate and Follicle-to-Oocyte Index in POSEIDON-Defined Low-Prognosis Women in Vietnam: A Cross-Sectional Study
por: Le, Minh Tam, et al.
Publicado: (2023)

NUCB2/Nesfatin-1 in the Blood and Follicular Fluid in Patients with Polycystic Ovary Syndrome and Poor Ovarian Response
por: Catak, Zekiye, et al.
Publicado: (2019)

Ovarian Follicular Atresia of Ewes during Spring Puerperium
por: Vlčková, Radoslava, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jhnchn30pqdgmuudcc2cdc6ig2